NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









neuro42

neuro42

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.neuro42.ai/

Last Round

Strategic

Aug 15, 2024

Total Funding Raised

$12.8M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

neuro42 is a medical technology company that develops a portable MRI, robotics, and artificial intelligence platform for the diagnosis and treatment of neurological conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical Devices, Medical AI

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

portable MRIneurosurgical roboticsintraoperative imagingimage-guided surgerymedical roboticsmagnetic resonance imagingMRIsurgical roboticspoint-of-care imagingAI-driven medical imagingsurgical navigationmedtechrobotic surgeryneurosurgery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

neuro42 Comps

Public and private peers based on sector, stage, and business model.

neuro42 comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

neuro42 Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicAug 15, 2024
VC RoundJun 10, 2024
AngelMay 2, 2024
GrantSep 29, 2023
Series AJul 27, 2021
Seed
Jan 1, 2021

Key People

Founding team and executive leadership

Nikhil Sadhwani

Chief Development Officer Co-Founder

Founding Team

Amit Vohra

Founder CEO

Founding Team

neuro42 Investors

Notable investors and investment history

neuro42 investors
InvestorRounds
NIH RADxGrant
Zynext VenturesStrategic
ShangBay CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 16, 2026

    Monthly visitors increased 68% MoM.

  • Sep 29, 2023

    $5M grant awarded by NIH RADx

neuro42 Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

neuro42 Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about neuro42's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range22
Year Founded2020
Last FundingAug 15, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.